We are live on ! Find out more
NC

NinePointTwo Capital Portfolio holdings

AUM $252M
1-Year Est. Return 12.98%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+12.98%
3 Year Est. Return
+1.62%
5 Year Est. Return
10 Year Est. Return
AUM
$258M
AUM Growth
-$6.98M
Cap. Flow
-$10.8M
Cap. Flow %
-4.2%
Top 10 Hldgs %
70.23%
Holding
341
New
84
Increased
4
Reduced
23
Closed
102

Sector Composition

Rank Sector Weight
1 Healthcare 9.03%
2 Technology 7.87%
3 Financials 3.44%
4 Industrials 2.76%
5 Consumer Discretionary 2.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SRPT icon
151
Sarepta Therapeutics
SRPT
$1.66B
$239K 0.09%
+2,095
New +$270K
TGI
152
DELISTED
Triumph Group
TGI
$239K 0.09%
19,368
HTH icon
153
Hilltop Holdings
HTH
$2.29B
$238K 0.09%
7,582
TPL icon
154
Texas Pacific Land
TPL
$28.9B
$238K 0.09%
+1,629
New +$261K
EPC icon
155
Edgewell Personal Care
EPC
$1.27B
$237K 0.09%
5,761
PM icon
156
Philip Morris
PM
$301B
$237K 0.09%
2,438
RCKT icon
157
Rocket Pharmaceuticals
RCKT
$348M
$237K 0.09%
11,936
ADT icon
158
ADT
ADT
$5.16B
$236K 0.09%
39,184
PLUG icon
159
Plug Power
PLUG
$2.92B
$235K 0.09%
22,640
AMGN icon
160
Amgen
AMGN
$203B
$234K 0.09%
1,058
EOG icon
161
EOG Resources
EOG
$78B
$234K 0.09%
2,046
GGG icon
162
Graco
GGG
$12.9B
$234K 0.09%
+2,710
New +$211K
ITOS
163
DELISTED
iTeos Therapeutics
ITOS
$234K 0.09%
17,677
-1,833
-9% -$26.1K
CVS icon
164
CVS Health
CVS
$137B
$232K 0.09%
3,357
CYTK icon
165
Cytokinetics
CYTK
$11B
$232K 0.09%
+7,140
New +$264K
GILD icon
166
Gilead Sciences
GILD
$161B
$232K 0.09%
3,014
RIG icon
167
Transocean
RIG
$5.92B
$232K 0.09%
33,190
WEC icon
168
WEC Energy
WEC
$37.7B
$232K 0.09%
2,633
IOVA icon
169
Iovance Biotherapeutics
IOVA
$2.23B
$231K 0.09%
+32,933
New +$236K
WM icon
170
Waste Management
WM
$95.9B
$230K 0.09%
1,329
PFE icon
171
Pfizer
PFE
$140B
$228K 0.09%
6,230
AAL icon
172
American Airlines Group
AAL
$9.58B
$227K 0.09%
12,660
MDGL icon
173
Madrigal Pharmaceuticals
MDGL
$12.6B
$227K 0.09%
+984
New +$267K
WERN icon
174
Werner Enterprises
WERN
$2.54B
$227K 0.09%
5,147
BMY icon
175
Bristol-Myers Squibb
BMY
$127B
$226K 0.09%
3,541

Similar funds

NinePointTwo Capital's Q2 2023 Portfolio in Review

As of Q2 2023, NinePointTwo Capital held 341 positions worth $258M, down 2.6% from $265M the previous quarter. Its ten largest holdings account for 70% of the portfolio.

NinePointTwo Capital withdrew a net $10.8M in Q2 2023, closing 102 positions and reducing 23 holdings. Its most notable exit was Accenture, an estimated $328K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 9% of assets, up from 7.3% a quarter earlier, followed by Technology and Financials.

Against the trend, NinePointTwo Capital opened a new position in Foot Locker worth $290K.

  • NinePointTwo Capital's largest Q2 2023 buy was Foot Locker: 10,699 shares worth $290K.
  • NinePointTwo Capital added most to PIMCO Enhanced Short Maturity Active Exchange-Traded Fund in Q2 2023, an estimated $674K increase.
  • NinePointTwo Capital's biggest Q2 2023 reduction was Schwab US TIPS ETF, cutting an estimated $5.01M.
  • NinePointTwo Capital fully exited Accenture in Q2 2023, selling an estimated $328K.
  • NinePointTwo Capital's ten largest holdings make up 70% of its $258M portfolio in Q2 2023.
  • NinePointTwo Capital opened 84 new positions and closed 102 in Q2 2023.
  • NinePointTwo Capital's portfolio value fell 2.6% quarter-over-quarter to $258M.

Based on NinePointTwo Capital's 13F filing for Q2 2023, filed 14 Aug 2023.